[2026 Medical Devices – Our Department in Action]
Dyne Medical Group Quality Team
Identifying defect types in real time and transforming data into assets —
2026 set as the first year of proactive quality management
Woongsub Ahn, Quality Team Leader:
“Quality improvement directly leads to cost reduction and production stability — we are establishing a virtuous cycle.”
[Medical News]
Dyne Medical Group (CEO: Sunghoon Lee), which has built a strong reputation in the global medical device market by leading the disposable flexible ureteroscope segment with advanced technology, is preparing for a second leap forward in 2026. Alongside its differentiated product competitiveness, the company is strengthening its internal foundation through a firm commitment to quality management.
In particular, the philosophy embodied in the phrase “Forward with Standards”—meaning “moving forward together with standards”—has become one of Dyne Medical Group’s strongest assets in earning the trust of physicians and patients.
Supporting this philosophy behind the scenes is the Quality Team within Dyne Medical Group’s Operations Division. In a recent interview with Medical News, Ungsub Ahn, Head of the Quality Team, explained that since joining the company, he has personally witnessed Dyne Medical Group’s differentiated competitiveness, driven by data-based quality innovation and the ability to translate regulations into the practical language of the manufacturing floor.
Advancing Standards, Not Standing Still: Dyne Medical’s Quality Philosophy
Ungsub Ahn explained that the phrase “Forward with Standards,” printed on Dyne Medical Group’s product manuals and packaging, captures the core direction of the Quality Team. Rather than passively following international standards, the company places standards at the center and moves proactively toward the future.
This philosophy closely aligns with Dyne Medical Group’s mission: to manufacture medical devices that physicians and patients can trust and use anytime, anywhere.
“Earning trust is not achieved through short-term tactics,” Ahn emphasized. “It is built through the consistent process of strictly adhering to standards and principles.”
Guided by this mission as its compass, the Quality Team continuously reflects on its purpose at every point of decision-making.
Moving Beyond Intuition: Building Trust Through Data
For Dyne Medical Group’s Quality Team, 2025 marked the first year of transforming quality records into data assets, going beyond simple documentation. Under the leadership of Ungsub Ahn, the team improved a process that previously required manual tracing of historical records to identify defect types in specific manufacturing stages. Today, necessary data can be extracted immediately based on accumulated datasets.
As defect issues that were once vaguely recognized by on-site personnel are now clearly defined through numerical data and documentation, a culture of communication based on evidence rather than intuition has taken root within the company.
“Knowing that the products we directly inspect and verify are manufactured, delivered, and trusted by patients gives our team members the greatest sense of pride,” Ahn added.
Practical Expertise That Connects Regulations and the Field
The core expertise of Dyne Medical Group’s Quality Team goes beyond a basic understanding of ISO 13485 quality management system requirements. The team applies strict international standards in a way that is optimized for real manufacturing environments, effectively connecting regulatory requirements with on-site operations.
In particular, when defects or abnormalities are identified in the field, the team does not stop at simply pointing them out. Each issue is clearly defined, root causes are identified in collaboration with related departments, and concrete solutions are developed. This hands-on expertise—detecting issues early, preventing their spread, and ensuring recurrence prevention—ultimately leads to improved patient safety.
Proactive Quality Management Driven by a Young, Flexible Organization
Disposable Flexible Ureteroscope “URUS”
Ungsub Ahn also cited the team’s flexible communication culture, fostered by a young organizational structure, as another key strength. Dyne Medical Group operates a flat culture in which employees address one another using the neutral honorific “-nim,” creating an environment where anyone can freely propose ideas and share concerns. This horizontal atmosphere lowers hierarchical barriers and enables faster and more precise discussions on quality-related issues.
Looking ahead, Dyne Medical Group’s Quality Team aims to take another step forward in 2026 by leveraging its accumulated data. While 2025 was the year of data collection, 2026 is positioned as the first year of proactive quality management, with a focus on preventing recurring issues before they occur.
By ensuring that quality improvements lead to greater production stability and cost reduction, the team is committed to supporting Dyne Medical Group’s flagship disposable flexible ureteroscope URUS in further strengthening its leadership in the global market.
Expressing his deep trust in the team, Ahn remarked,
“I am confident that in five or ten years, our team members will grow into core leaders of the organization and practical experts who will lead the global medical device market.”
Concluding the interview, Ungsub Ahn stated,
“Our goal is not to be an organization that steps in after problems occur, but one that moves first through data analysis before issues arise. We aim to establish a virtuous cycle in which quality improvement leads directly to cost reduction and production stability.”
[2026 Medical Devices – Our Department in Action]
Dyne Medical Group Quality Team
Identifying defect types in real time and transforming data into assets —
2026 set as the first year of proactive quality management
Woongsub Ahn, Quality Team Leader:
“Quality improvement directly leads to cost reduction and production stability — we are establishing a virtuous cycle.”
[Medical News]
Dyne Medical Group (CEO: Sunghoon Lee), which has built a strong reputation in the global medical device market by leading the disposable flexible ureteroscope segment with advanced technology, is preparing for a second leap forward in 2026. Alongside its differentiated product competitiveness, the company is strengthening its internal foundation through a firm commitment to quality management.
In particular, the philosophy embodied in the phrase “Forward with Standards”—meaning “moving forward together with standards”—has become one of Dyne Medical Group’s strongest assets in earning the trust of physicians and patients.
Supporting this philosophy behind the scenes is the Quality Team within Dyne Medical Group’s Operations Division. In a recent interview with Medical News, Ungsub Ahn, Head of the Quality Team, explained that since joining the company, he has personally witnessed Dyne Medical Group’s differentiated competitiveness, driven by data-based quality innovation and the ability to translate regulations into the practical language of the manufacturing floor.
Advancing Standards, Not Standing Still: Dyne Medical’s Quality Philosophy
Ungsub Ahn explained that the phrase “Forward with Standards,” printed on Dyne Medical Group’s product manuals and packaging, captures the core direction of the Quality Team. Rather than passively following international standards, the company places standards at the center and moves proactively toward the future.
This philosophy closely aligns with Dyne Medical Group’s mission: to manufacture medical devices that physicians and patients can trust and use anytime, anywhere.
“Earning trust is not achieved through short-term tactics,” Ahn emphasized. “It is built through the consistent process of strictly adhering to standards and principles.”
Guided by this mission as its compass, the Quality Team continuously reflects on its purpose at every point of decision-making.
Moving Beyond Intuition: Building Trust Through Data
For Dyne Medical Group’s Quality Team, 2025 marked the first year of transforming quality records into data assets, going beyond simple documentation. Under the leadership of Ungsub Ahn, the team improved a process that previously required manual tracing of historical records to identify defect types in specific manufacturing stages. Today, necessary data can be extracted immediately based on accumulated datasets.
As defect issues that were once vaguely recognized by on-site personnel are now clearly defined through numerical data and documentation, a culture of communication based on evidence rather than intuition has taken root within the company.
“Knowing that the products we directly inspect and verify are manufactured, delivered, and trusted by patients gives our team members the greatest sense of pride,” Ahn added.
Practical Expertise That Connects Regulations and the Field
The core expertise of Dyne Medical Group’s Quality Team goes beyond a basic understanding of ISO 13485 quality management system requirements. The team applies strict international standards in a way that is optimized for real manufacturing environments, effectively connecting regulatory requirements with on-site operations.
In particular, when defects or abnormalities are identified in the field, the team does not stop at simply pointing them out. Each issue is clearly defined, root causes are identified in collaboration with related departments, and concrete solutions are developed. This hands-on expertise—detecting issues early, preventing their spread, and ensuring recurrence prevention—ultimately leads to improved patient safety.
Proactive Quality Management Driven by a Young, Flexible Organization
Disposable Flexible Ureteroscope “URUS”
Ungsub Ahn also cited the team’s flexible communication culture, fostered by a young organizational structure, as another key strength. Dyne Medical Group operates a flat culture in which employees address one another using the neutral honorific “-nim,” creating an environment where anyone can freely propose ideas and share concerns. This horizontal atmosphere lowers hierarchical barriers and enables faster and more precise discussions on quality-related issues.
Looking ahead, Dyne Medical Group’s Quality Team aims to take another step forward in 2026 by leveraging its accumulated data. While 2025 was the year of data collection, 2026 is positioned as the first year of proactive quality management, with a focus on preventing recurring issues before they occur.
By ensuring that quality improvements lead to greater production stability and cost reduction, the team is committed to supporting Dyne Medical Group’s flagship disposable flexible ureteroscope URUS in further strengthening its leadership in the global market.
Expressing his deep trust in the team, Ahn remarked,
“I am confident that in five or ten years, our team members will grow into core leaders of the organization and practical experts who will lead the global medical device market.”
Concluding the interview, Ungsub Ahn stated,
“Our goal is not to be an organization that steps in after problems occur, but one that moves first through data analysis before issues arise. We aim to establish a virtuous cycle in which quality improvement leads directly to cost reduction and production stability.”